DETERMINATION OF NIMODIPINE AND ITS DEHYDROGENATION METABOLITE IN HUMAN LIVER MICROSOME BY HPLC AND ITS METABOLIZING KINETICS

Xiaoquan Liu,Xiaoxiao Yu,Erli Wang,Guangji Wang,Zhiyu Qian
DOI: https://doi.org/10.3321/j.issn:0513-4870.2000.04.005
2000-01-01
Abstract:AIM: To develop an HPLC method for the determination of nimodipine and its major metabolite as well as the kinetics of its metabolism in human liver microsomes. METHODS: Chromatography was performed on an Hypersil BDS C18 column. An acetonitrile-water(62:38) mixture as the mobile phase was used with the UV detector set at 238 nm. Following alkalinization with NaOH human liver microsomes were extracted with n-hexane-ether(1:1). RESULTS: The recovery of of nimodipine and its major metabolite for the proposed method was more than 94.3%. The relative standard deviations for within-day and between-day were <9.68%. The calibration curve was linear in the range from 1.31 to 20.92 μg·mL-1 with γ = 0.9997 for nimodipine and from 122.7 to 4908.0 ng·mL-1 with γ = 0.9995 for its dehydrogenation metabolite. The elimination of nimodipine and the formation of dehydrogenation metabolite was linear. CONCLUSION: Nimodipine was rapidly metabolized to its dehydrogenated metabolite in human liver microsomes. Our results showed that human liver CYP450 was involved in the oxidation of dihydropyridine ring of nimodipine.
What problem does this paper attempt to address?